Physician profile
Anthony Tedesco
NPI 1275940371
$38,982.67
in general payments reported to CMS, 2019-2025
15 companies · $124 in 2025
The $124 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24K · 2020: $6,799 · 2021: $1,215 · 2022: $4,067 · 2023: $135 · 2024: $2,190 · 2025: $124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,502 · Food and Beverage: $947.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,501.67 |
| Food and Beverage | $946.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $19,237.85 | 2019-2024 | |
| Smith+Nephew, INC. | $13,369.30 | 2019-2023 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Wardlow Enterprises | $2,060.42 | 2020-2022 | |
| Wright Medical Technology, INC. | $1,456.15 | 2019 | |
| Zimmer Biomet Holdings, INC. | $1,234.40 | 2019-2020 | |
| Prism Medical | $962.12 | 2024 | |
| Depuy Synthes Sales INC. | $222.59 | 2020-2025 | Tfn-Advance, Monovisc |
| Pacira Pharmaceuticals Incorporated | $150.61 | 2019-2024 | Exparel, Zilretta, Iovera |
| Globus Medical, INC. | $113.11 | 2022-2024 | Legacy Stelkast Knee, Onvoy |
| Stryker Corporation | $64.10 | 2023 | Gamma, Inspace |
| Vertex Pharmaceuticals Incorporated | $50.42 | 2024-2025 | |
| Heron Therapeutics, INC. | $18.45 | 2023 | Zynrelef |
| Convatec INC. | $17.15 | 2024 | |
| Vericel Corporation | $13.88 | 2024 | Maci |
| Rock Medical Orthopedics, INC. | $12.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Tedesco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.